<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01102751</url>
  </required_header>
  <id_info>
    <org_study_id>Istanbul University</org_study_id>
    <secondary_id>Research Fund</secondary_id>
    <nct_id>NCT01102751</nct_id>
  </id_info>
  <brief_title>Serum FGF-23 and Vitamin D Deficiency</brief_title>
  <official_title>Effects Of Vitamin D Replacement Therapy on Serum FGF-23 Concentrations in Vitamin D Deficient Women In Short Term</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aimed to determine the effect of vitamin D replacement therapy on serum FGF-23&#xD;
      concentrations in vitamin D deficient women and to compare the FGF-23 concentrations of&#xD;
      vitamin D deficient patients with healthy subjects and patients with genetically-determined&#xD;
      hypophosphatemic rickets.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study group was composed of vitamin D deficient females (n =18, mean age 29.1±9.9 yrs),&#xD;
      vitamin D sufficient healthy females (control group; n = 19, mean age 28.5±5.2 yrs) and&#xD;
      patients with genetically-determined hypophosphatemic rickets (n=13, mean age 26.5±15.1 yrs).&#xD;
      Groups were compared for serum FGF-23, 1,25 dihydroxy vitamin D3, calcium, phosphate, bone&#xD;
      turnover markers, intact parathyroid hormone and urinary excretion of calcium and phosphate.&#xD;
      Vitamin D deficient group was re-evaluated after a standard treatment regimen.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <condition>Osteomalacia</condition>
  <arm_group>
    <arm_group_label>Vitamin D deficient females</arm_group_label>
    <description>(n =18, mean age 29.1±9.9 yrs)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamin D sufficient healthy females</arm_group_label>
    <description>(control group; n = 19, mean age 28.5±5.2 yrs)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>genetically-determined hypophosphatemic rahitis</arm_group_label>
    <description>(n=13, mean age 26.5±15.1 yrs)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Group 1: Eighteen premenopausal female patients with a diagnosis of vitamin D deficient&#xD;
        osteomalacia were included in this group. Vitamin D deficiency was diagnosed according to&#xD;
        the serum 25 hydroxy vitamin D3 (25OHD) concentrations (&lt; 30 ng/mL). Reasons for vitamin D&#xD;
        deficiency were verified as insufficient exposure to sunlight, frequent parturition and&#xD;
        prolonged lactation. All of these patients received a standard treatment regimen; oral&#xD;
        Vitamin D3 150 000 IU once for all and subsequently 880 IU D3 and 1000 mg calcium carbonate&#xD;
        for six weeks. This group was also evaluated after replacement therapy at sixth week.&#xD;
&#xD;
        Group 2: Nineteen healthy premenopausal women who had normal levels of serum 25OHD Vitamin&#xD;
        (&gt;30 ng/mL) composed the control group.&#xD;
&#xD;
        Group 3: Thirteen hypophosphatemic rickets (3 autosomal dominant and 10 X-linked; 9 female&#xD;
        and 4 male) were included in this group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Serum 25OHD Vitamin &lt;30 ng/mL for group 1&#xD;
&#xD;
          -  Serum 25OHD Vitamin &gt;30 ng/mL for control group&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Receiving medication(s) affecting bone metabolism&#xD;
&#xD;
          -  History of gastrointestinal disease and malabsorption&#xD;
&#xD;
          -  History of renal and liver disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism</name>
      <address>
        <city>Istanbul</city>
        <zip>34390</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <study_first_submitted>April 12, 2010</study_first_submitted>
  <study_first_submitted_qc>April 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2010</study_first_posted>
  <last_update_submitted>April 12, 2010</last_update_submitted>
  <last_update_submitted_qc>April 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2010</last_update_posted>
  <keyword>fibroblast growth factor 23</keyword>
  <keyword>Osteomalacia</keyword>
  <keyword>vitamin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteomalacia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

